These innovative medications , Retatrutide, represent a groundbreaking advancement in treating type 2 diabetes and potentially other ailments . They all are categorized as GLP-1 pathway agonists , signifying they to replicate the endogenous GLP-1 hormone , enhancing glucose release and lowering appetite . Although Tirzepatide every operates relativ